| Jan'20 | Oct'19 | Jul'19 | Apr'19 | Jan'19 | Oct'18 | Jul'18 | Apr'18 | Jan'18 | Oct'17 | Jul'17 | Apr'17 | Jan'17 | Oct'16 | Jul'16 | Apr'16 | Jan'16 | Oct'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating activities | |||||||||||||||||
Net income (loss) | |||||||||||||||||
100,000 | -801,000 | -1,202,000 | -1,196,000 | -240,000 | -706,000 | -261,000 | -309,000 | -173,000 | -820,000 | -208,000 | -239,000 | -327,000 | 163,000 | -779,000 | 326,000 | 1,111,000 | 325,000 |
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||||||||
Depreciation and amortization | |||||||||||||||||
363,000 | 505,000 | 405,000 | 391,000 | 328,000 | 303,000 | 334,000 | 317,000 | 225,000 | 157,000 | 156,000 | 165,000 | 184,000 | 138,000 | 135,000 | 153,000 | 157,000 | 160,000 |
Deferred income taxes | |||||||||||||||||
- | - | - | - | - | - | 165,000 | 1,000 | 5,000 | 1,000 | -32,000 | -1,000 | 0 | 5,000 | -26,000 | 0 | 0 | 0 |
Stock-based compensation | |||||||||||||||||
198,000 | 98,000 | 170,000 | 118,000 | 210,000 | 121,000 | 166,000 | 157,000 | 199,000 | 73,000 | 66,000 | 66,000 | 116,000 | 27,000 | 156,000 | 1,000 | 3,000 | 6,000 |
Stock issued to FreeForm noteholders | |||||||||||||||||
- | - | - | - | - | - | 0 | 0 | 0 | 242,000 | 0 | 0 | 0 | 0 | - | - | - | - |
Change in assets and liabilities: | |||||||||||||||||
Trade accounts receivable | |||||||||||||||||
-34,000 | -68,000 | -71,000 | -153,000 | 121,000 | -541,000 | 98,000 | -140,000 | -79,000 | 186,000 | -77,000 | 173,000 | -62,000 | 11,000 | -112,000 | -570,000 | 398,000 | 330,000 |
Prepaid expenses and other current assets | |||||||||||||||||
-36,000 | -207,000 | -99,000 | 29,000 | 31,000 | -238,000 | 84,000 | -54,000 | 32,000 | -170,000 | 297,000 | -74,000 | -6,000 | 264,000 | 100,000 | 54,000 | -166,000 | 106,000 |
Other assets | |||||||||||||||||
0 | 13,000 | - | - | - | -3,000 | -4,000 | -5,000 | 8,000 | -4,000 | 10,000 | -4,000 | 0 | 2,000 | -6,000 | 19,000 | -2,000 | -4,000 |
Trade accounts payable and accrued expenses | |||||||||||||||||
-400,000 | 192,000 | -410,000 | 205,000 | -514,000 | 408,000 | -687,000 | 172,000 | -94,000 | 438,000 | -42,000 | 107,000 | -57,000 | 392,000 | -266,000 | -28,000 | -178,000 | 511,000 |
Due to IDT Corporation | |||||||||||||||||
- | - | - | 0 | -14,000 | 13,000 | -2,000 | -6,000 | -54,000 | 27,000 | -20,000 | -21,000 | 4,000 | -226,000 | -159,000 | 94,000 | 88,000 | -93,000 |
Deferred revenues | |||||||||||||||||
242,000 | 96,000 | - | - | - | - | - | - | - | - | -1,000 | 0 | -7,000 | -7,000 | 12,000 | -1,000 | 4,000 | -4,000 |
Net cash provided by operating activities | |||||||||||||||||
573,000 | 352,000 | -395,000 | -65,000 | -385,000 | 921,000 | -452,000 | 531,000 | 147,000 | 106,000 | -284,000 | -18,000 | -10,000 | 215,000 | - | - | - | - |
Investing activities | |||||||||||||||||
Net cash provided by operating activities | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,042,000 | 955,000 | 473,000 |
Capitalized software and technology development costs and purchase of equipment | |||||||||||||||||
204,000 | 213,000 | 213,000 | 361,000 | 471,000 | 445,000 | 407,000 | 497,000 | 310,000 | 488,000 | 266,000 | 483,000 | 408,000 | 349,000 | 326,000 | 336,000 | 161,000 | 183,000 |
Investment in privately-held company | |||||||||||||||||
- | - | 0 | 0 | 0 | 250,000 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net cash used in investing activities | |||||||||||||||||
-204,000 | -213,000 | -213,000 | -361,000 | -471,000 | -695,000 | -407,000 | -497,000 | -310,000 | -488,000 | -266,000 | -483,000 | -408,000 | -349,000 | - | - | - | - |
Financing activities | |||||||||||||||||
Repayment of insurance premium loan payable | |||||||||||||||||
47,000 | 31,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net cash used in investing activities | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -336,000 | -161,000 | -183,000 |
Proceeds from exercise of stock options | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | -1,000 | 1,000 | 42,000 | 124,000 | 0 | 9,000 | 0 | 0 |
Purchase of treasury stock in connection with restricted stock vesting | |||||||||||||||||
7,000 | 22,000 | 16,000 | 0 | 0 | 31,000 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net cash provided by (used in) financing activities | |||||||||||||||||
225,000 | -53,000 | -13,000 | 2,000 | 0 | -31,000 | 16,000 | 125,000 | 91,000 | 0 | -1,000 | 1,000 | 42,000 | 124,000 | - | - | - | - |
Net cash provided by financing activities | |||||||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9,000 | 0 | 0 |
Effect of exchange rate changes on cash and cash equivalents | |||||||||||||||||
-1,000 | -36,000 | -18,000 | -32,000 | -1,000 | -42,000 | -21,000 | -47,000 | 69,000 | -35,000 | 49,000 | -22,000 | -3,000 | 15,000 | -44,000 | 68,000 | -34,000 | -27,000 |
Net increase (decrease) in cash and cash equivalents | |||||||||||||||||
593,000 | 50,000 | -639,000 | -456,000 | -857,000 | 153,000 | -864,000 | 112,000 | -3,000 | -417,000 | -502,000 | -522,000 | -379,000 | 5,000 | 2,002,000 | 783,000 | 760,000 | 263,000 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||||||||||||||||
Cash payments made for interest expenses | |||||||||||||||||
1,000 | 1,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |